Mary Beth Beasley

29.1k citations
108 papers · 8.2k indexed · 4 hit papers · h-index 39

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Medical Imaging and Pathology Studies
  • Oncology top 0.5%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Lung Cancer Treatments and Mutations 28
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 24
    • Medical Imaging and Pathology Studies 20
    • Lung Cancer Diagnosis and Treatment 19
    • Pleural and Pulmonary Diseases 8

Mary Beth Beasley

105 papers receiving 8.0k citations

Hit Papers

PD-L1 as a biomarker of response to immune-checkpoint inhibitors 2021 · 980 citations
9802011202620162021250500750

Peers

Mary Beth Beasley
Comparison fields: 5 of 126
  • Pulmonary and Respiratory Medicine 4.8k
  • Oncology 3.6k
  • Cancer Research 1.6k
  • Microbiology 38
  • Epidemiology 1.4k
Replace Giulio Rossi with:
Giulio Rossi Italy
Thomas Muley Germany
Alain Borczuk United States
Marco Alifano France
Takehiko Fujisawa Japan
Jacques Cadranel France
Ichiro Yoshino Japan
Philip T. Cagle United States
Hendrik Dienemann Germany
Douglas B. Flieder United States
Mary Beth Beasley relative to Giulio Rossi Italy Giulio Rossi's profile →
Citations per field
00.5×1.5×
Giulio Rossi · 1×
Citations per year

Countries citing papers authored by Mary Beth Beasley

Since Specialization
Citations

This map shows the geographic impact of Mary Beth Beasley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Beth Beasley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Beth Beasley more than expected).

Fields of papers citing papers by Mary Beth Beasley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Beth Beasley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Beth Beasley. The network helps show where Mary Beth Beasley may publish in the future.

Co-authors

The 25 scholars most cited alongside Mary Beth Beasley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mary Beth Beasley Line = papers co-authored together Mary Beth Beasley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202411
2 202147
3
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
Hit paper breakdown →
2021752
4 202115
5 20200
6 202018
7 2020308
8 201926
9 20199
10 201855
11 201759
12 20167
13 201648
14 20152
15 201410
16 20145
17 2013367
18 201241
19 200720
20 2002292

About Mary Beth Beasley

Mary Beth Beasley is a scholar working on Microbiology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Rheumatology, having authored 108 papers that have together received 8.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (28 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (24 papers), Medical Imaging and Pathology Studies (20 papers), Lung Cancer Diagnosis and Treatment (19 papers), Lung Cancer Research Studies (14 papers), Cancer Genomics and Diagnostics (10 papers), Pleural and Pulmonary Diseases (8 papers) and Neuroendocrine Tumor Research Advances (8 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.8k citations), Oncology (3.6k citations), Cancer Research (1.6k citations), Microbiology (38 citations) and Epidemiology (1.4k citations). Mary Beth Beasley has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include William D. Travis, Sanja Đačić, Élisabeth Brambilla, Giuseppe Giaccone, Philip T. Cagle, Keith M. Kerr, Lynette M. Sholl, Ming‐Sound Tsao, Robert B. Jenkins and Erik Thunnissen. Their work appears in journals such as Archives of Pathology & Laboratory Medicine, Journal of Thoracic Oncology, The American Journal of Surgical Pathology, Journal of Clinical Oncology and Human Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026